Fig. 2From: Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)Disease-free survival (full analysis set) (a) and overall survival (full analysis set) (b)Back to article page